Vigil Neuroscience Inc (VIGL) concluded trading on Thursday at a closing price of $7.87, with 3.58 million shares of worth about $28.2 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 246.70% during that period and on June 12, 2025 the price saw a gain of about 0.13%. Currently the company’s common shares owned by public are about 46.67M shares, out of which, 29.90M shares are available for trading.
Stock saw a price change of -0.13% in past 5 days and over the past one month there was a price change of 212.30%. Year-to-date (YTD), VIGL shares are showing a performance of 362.94% which increased to 78.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.31 but also hit the highest price of $7.95 during that period. The average intraday trading volume for Vigil Neuroscience Inc shares is 1.03 million. The stock is currently trading 20.71% above its 20-day simple moving average (SMA20), while that difference is up 108.06% for SMA50 and it goes to 161.82% higher than SMA200.
Vigil Neuroscience Inc (NASDAQ: VIGL) currently have 46.67M outstanding shares and institutions hold larger chunk of about 52.34% of that.
The stock has a current market capitalization of $367.30M and its 3Y-monthly beta is at 3.43. It has posted earnings per share of -$2.06 in the same period. It has Quick Ratio of 2.97 while making debt-to-equity ratio of 0.19. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VIGL, volatility over the week remained 0.16% while standing at 27.57% over the month.
Analysts are in expectations that Vigil Neuroscience Inc (VIGL) stock would likely to be making an EPS of -0.47 in the current quarter, while forecast for next quarter EPS is -0.48 and it is -1.61 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.5 which is -0.43 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.52 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 11.29% while it is estimated to increase by 7.35% in next year. EPS is likely to grow at an annualized rate of 8.10% for next 5-years, compared to annual growth of -19.68% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on May 28, 2025 offering a Hold rating for the stock and assigned a target price of $8 to it. On December 19, 2023, Morgan Stanley Downgrade their recommendations, while on October 18, 2023, JMP Securities Initiated their ratings for the stock with a price target of $23. Stock get a Buy rating from Mizuho on March 31, 2023.
